Folic Acid Supplement Prevents Phenytoin-Induced Gingival Hyperplasia
Researchers at the Division of Pediatric Neurology, Neurosciences Centre, New Delhi, India, performed a randomized, double-blind, placebo-controlled 6-month trial of oral folic acid supplement (0.5 mg/day) in children aged 6-15 years treated with phenytoin for epilepsy.
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Pediatric Neurology Briefs Publishers
2011-05-01
|
| Serie: | Pediatric Neurology Briefs |
| Soggetti: | |
| Accesso online: | https://www.pediatricneurologybriefs.com/articles/632 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|